SENSEONICS HOLDINGS INC (SENS)
US81727U1051 - Common Stock
Friday's after hours session: top gainers and losers
Curious about the stocks that are showing activity after the closing bell on Friday?
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
$16 million upfront with the potential for an additional $16 million upon the exercise in full of warrants...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management...
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
SENS Stock Earnings: Senseonics Holdings Meets EPS, Misses Revenue for Q2 2024
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Sidoti Events, LLC's Virtual June Small-Cap Conference
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
SENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
Eversense® CGM System Receives iCGM Designation by the US FDA
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
Senseonics stock slips after Q4 results (NYSE:SENS)
Senseonics Holdings (SENS) stock fell 9% despite a Q4 beat as analysts pointed to concerns over demand for its Eversense glucose monitoring device. Read more here.
Senseonics GAAP EPS of -$0.03 beats by $0.01, revenue of $8M beats by $0.38M (NYSE:SENS)
Senseonics beats expectations with Q4 earnings as GAAP EPS comes in at -$0.03, surpassing estimates by $0.01.
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Notable earnings after Thursday's close
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM
/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...
3 Penny Stocks to Watch for Explosive Growth in Q1 2024
Make sure you have your sights set on these penny stocks to watch. Each has a strong upside and positive growth prospects for the future.
Senseonics Holdings expects to report Q4 revenues of about $8M (NYSE:SENS)
Senseonics Holdings expects to report revenues of $8 million for Q4 2023 and $22 million for full year 2023, with cash balance of $109.8 million.
Senseonics Holdings, Inc. Announces Business Updates
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
